Search Clinical Trials—Center for Information & Study on Clinical Research Participation

Links shared publicly online about this topic.

  • 1,403
    total visits

Search Clinical Trials—Center for Information & Study on Clinical Research Participation

searchclinicaltrials.org

Search Clinical Trials—Center for Information & Study on Clinical Research Participation

View full resource at searchclinicaltrials.org

Tags: Clinical Trial

  • Share

Most Recently Shared on February 21, 2012 at 8:52 pm By:

CISCRP CISCRP

Do you need help finding a clinical trial? We will do a personalized search for you by clicking here! http://t.co/dotTwVJR

2 years ago...

Study: Use of drug following first sign of possible MS reduces likelihood of progression to MS

eurekalert.org — “People who received injections of the multiple sclerosis (MS) drug interferon beta-1a soon after their first signs of possible MS were less likely to progress to clinically definite MS than people who switched to interferon beta-1a from placebo, according to new phase three results of the three-year REFLEXION clinical trial that will be presented as part of the Emerging Science program at the American Academy of Neurology's 64th Annual Meeting in New Orleans, April 21-28, 2012.View full resource at eurekalert.org

  • View Related
  • Share

Most Recently Shared on April 20, 2012 at 7:17 am By:

Neurology_OW Neurology OW OW Health

Study: Use of drug following first sign of possible MS reduces likelihood of progression to MS: ( American Acade... http://t.co/DJO0pAcf

6 days ago...

Revised View Enhances Provenge OS Data

onclive.com — “A further analysis of clinical trial data for sipuleucel-T suggests that it may have delivered a greater OS benefit than previously described.View full resource at onclive.com

  • View Related
  • Share

Most Recently Shared on April 19, 2012 at 9:28 pm By:

Sanofi and Michael J. Fox Foundation Collaborate on Potential New Treatment for Parkinson's... -- PARIS, April 19, 2012 /PRNewswire/ --

prnewswire.com — “Sanofi and Michael J. Fox Foundation Collaborate on Potential New Treatment for Parkinson's Disease. - Fox Foundation to sponsor a clinical trial to study Sanofi compound -.View full resource at prnewswire.com

  • View Related
  • Share

Most Recently Shared on April 19, 2012 at 1:15 pm By:

sstrumello Scott Strumello Patient Expert

PR: Sanofi and Michael J. Fox Foundation Collaborate on Potential New Treatment for Parkinson's http://t.co/VR1kr3k3 via @PRNewswire

7 days ago...

Vaccine extends life of brain cancer patients - Yahoo! News India

in.news.yahoo.com — “'Vaccine extends life of brain cancer patients' on Yahoo! News India. Washington, April 19 (IANS) A new brain cancer vaccine, which uses material from patients' own tumours, holds promise of extending their lives by several months, show results of a multicentre phase-two clinical trial of the vaccine.View full resource at in.news.yahoo.com

  • View Related
  • Share

Most Recently Shared on April 19, 2012 at 1:05 pm By:

BrainCancer_OW Brain Cancer OW OW Health

Vaccine extends life of brain cancer patients: Washington, April 19 (IANS) A new brain cancer vaccine, which use... http://t.co/Ui9dfsdf

7 days ago...

New Brain Cancer Vaccine Displays Success In Second Clinical Trial - Health News - redOrbit

redorbit.com — “On Tuesday, April 17, researchers from the University of California, San Francisco (UCSF) presented results at the American Association of Neurological Surgeons (AANS) meeting in Miami, Florida that a new brain cancer vaccine tailored to individual subjects had been successful in its second clinical trial.View full resource at redorbit.com

  • View Related
  • Share

Most Recently Shared on April 18, 2012 at 7:03 pm By:

BrainCancer_OW Brain Cancer OW OW Health

New Brain Cancer Vaccine Displays Success In Second Clinical Trial: Connie K. Ho for http://t.co/nBP7sQqf On Tues... http://t.co/iwLUkdAv

1 week ago...

Medgenics seeks IND approval to initiate EPODURE Biopump Phase IIb anemia study in ESRD patients

news-medical.net — “Medgenics, Inc., the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that it has filed an Investigational New Drug application with the U.S. Food and Drug Administration to initiate a Phase IIb multi-center, 100-patient clinical trial.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on April 18, 2012 at 4:01 pm By:

Diabetes_Med News-Medical.Net Health News

Diabetes News: Medgenics seeks IND approval to initiate EPODURE Biopump Phase IIb anemia study in ESRD patients:... http://t.co/ol32Ok8K

1 week ago...

Drug May Lower Gluten Toxicity in Patients with Celiac Disease - Celiac.com

celiac.com — “Biopharmaceutical development company, BioLineRx, has announced results from pre-clinical trials which show that their compound, BL-7010, an orally available treatment for celiac disease, reduces the ...View full resource at celiac.com

  • View Related
  • Share

Most Recently Shared on April 18, 2012 at 9:19 am By:

csaceliacs csaceliacs Health Organization

Drug May Lower Gluten Toxicity in Patients with Celiac Disease - http://t.co/2y1rcrPk http://t.co/r31MN96a #GF #Celiac

1 week ago...

Idera commences IMO-3100 Phase 2 clinical trial for psoriasis

news-medical.net — “Idera Pharmaceuticals, Inc. today announced the treatment of the first patient in a Phase 2 clinical trial of IMO-3100, the Company's lead Toll-like receptor (TLR) inhibitor for the treatment of autoimmune diseases, in patients with moderate to severe plaque psoriasis.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on April 18, 2012 at 6:26 am By:

NewsMedical News-Medical.Net Health News

Idera commences IMO-3100 Phase 2 clinical trial for psoriasis: Idera Pharmaceuticals, Inc. today announced the t... http://t.co/wEfJcG0T

1 week ago...

Pharmaxis asthma treatment found safe, but is it effective? - Pharmaxis, immunology, Drug Development, clinical trials, Biotechnology, asthma - Australian Life Scientist

lifescientist.com.au — “A phase IIa trial of Pharmaxis’ (ASX:PXS) experimental allergic asthma drug, ASM8, has been shown safe, but more trials will be required to demonstrate efficacy.View full resource at lifescientist.com.au

  • View Related
  • Share

Most Recently Shared on April 17, 2012 at 7:08 pm By:

wheezemd Michael Blaiss, MD Physician, Doctor, and Allergist

Pharmaxis asthma treatment found safe, but is it effective? - http://t.co/afcJp0X8

1 week ago...

Shot Delivers Scant Relief for Back Pain (CME/CE) - QualityPoint Technologies

qualitypointtech.net — “(MedPage Today) -- Epidural injections provided modest short-term pain relief from lumbrosacral radiculopathy, whether used with steroids or an anti-inflammatory biologic agent, a clinical trial showed.View full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on April 17, 2012 at 5:45 pm By:

MedicalFeed MedicalFeed Health News Feed

Shot Delivers Scant Relief for Back Pain (CME/CE): (MedPage Today) -- Epidural injections provided modest short-te... http://t.co/maY4gt8n

1 week ago...

Pilot Study 1 of Outpatient Control-to-Range - System and Monitoring Testing - Full Text View - ClinicalTrials.gov

clinicaltrials.gov — “Pilot Study 1 of Outpatient Control-to-Range - System and Monitoring Testing - Full Text View - ClinicalTrials.govView full resource at clinicaltrials.gov

  • View Related
  • Share

Most Recently Shared on April 17, 2012 at 5:32 pm By:

nataliehodgePersonal Medicine in Paducah, Kentucky. Dr Hodge was a featured speaker at the Mayo Clinic's Transform Symposium in '09 and has been named by Brian Dolan of Mobi Heath News as "The First iPhone Doctor". She is the author of The Personal Pediatrics Primer for the Progressive Parent.

Dr. Hodge's special interests in pediatrics include nutrition, prevention and the potential for the internet to strengthen physician patient relationships. Dr. Hodge is a member of the Health care Information and Management Systems Society (HIMSS), a Fellow of the Academy of Pediatrics' Quality and Innovation Network, and a founding member of the Society for Participatory Medicine. Participatory Medicine is an emerging group of engaged patients and physicians who believe that mutual trust and understanding as well as use of media, health IT strengthens the physician patient relationship and provides for better care." /> Natalie Hodge, MD, FAAP Pediatrician, Physician, Active Health Library, and Doctor

Pilot Study 1 of Outpatient Control-to-Range - System and Monitoring Testing http://t.co/bhrtpYpP cool hotel room and a cell phone #cure

1 week ago...

Increasing the Effectiveness of Multinational and Multi-Site Clinical Trials Webinar

within3.com — “Increasing the Effectiveness of Multinational and Multi-Site Clinical Trials WebinarView full resource at within3.com

  • View Related
  • Share

Most Recently Shared on April 17, 2012 at 12:30 pm By:

Within3 Within3 Support

Webinar: Online #Clinical Communities — Platforms to Collaborate, Improve Efficiency of #ClinicalTrials http://t.co/YDgnSihj #ClinCom

1 week ago...

BMJ Careers - Government is accused of using clinical excellence awards as “a political bargaining chip”

careers.bmj.com — “Search thousands of high quality medical careers advice articles written by doctors, ranging from how to write a CV to changing medical specialty.View full resource at careers.bmj.com

  • View Related
  • Share

Most Recently Shared on April 17, 2012 at 7:48 am By:

helenjaques Helen Jaques Health Communicator

BMJ Careers news: Government is accused of using clinical excellence awards as “a political bargaining chip” http://t.co/avw4G3oR

1 week ago...

Research roundup: Obesity treatment for low-income patients; Medicare vs. private plans

news-medical.net — “Low-income patients are underrepresented in clinical trials and are disproportionately prone to obesity and the related problems of high blood pressure and heart disease. Researchers conducted a 24-month trial of more than 300 low-income, obese patients from various Boston community health centers, randomizing participants "to usual care or a behavioral intervention that promoted weight loss and hypertension self-management using eHealth components. The intervention included tailored behaviView full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on April 16, 2012 at 10:10 am By:

Medicare_News News-Medical.Net Health News

Medicare News: Research roundup: Obesity treatment for low-income patients; Medicare vs. private plans: Low-inco... http://t.co/B4HhfRqn

1 week ago...

Improving care transitions with technology - Search Eldercare

searcheldercare.com — “Long-term care facilities have always had their eye on hospital readmissions, especially after PPS was instituted, to avoid additional payment for emergency room services if the resident was not admitted. It is a win-win proposition for facilities to refocus their energy and effort to reduce rehospitalizations. The good news is that the technology has improved significantly, making this task easier.View full resource at searcheldercare.com

  • View Related
  • Share

Most Recently Shared on April 13, 2012 at 6:45 pm By:

hcs_emr_rcm Health Care Software Health IT and Health Business

Carrie O'Connell, VP of Clinical Development at HCS, discusses improving care transitions with technology... http://t.co/ZqLCXlor

2 weeks ago...

Advertisement